Thermo Fisher Scientific | TMO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.81B 49M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Bio Techne USD 209.82M 36.94M 2026-03
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
Edwards Lifesciences USD 2.4B 538M 2026-03
General Electric Aerospace USD 10.98B 1.41B 2026-03
Henry Schein USD 138M 18M 2026-03
Illumina USD 1.42B 368M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Medtronic USD 1.15B 135M 2025-12
Mettler Toledo International USD 66.89M 2.18M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
Olympus JPY 147.24B 93.98B 2025-09
OraSure Technologies USD 176.96M 22.31M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Repligen USD 582.65M 16.63M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 263.14M 99.44M 2026-03
Waters USD 462M 125.83M 2026-03
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03